Stay updated on Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision: v3.6.3 was added, indicating an updated version of the Study Protocol and Statistical Analysis Plan document. The previous revision (v3.6.2) was removed.
    Difference
    0.1%
    Check dated 2026-07-03T22:25:01.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2, replacing the previous Revision: v3.6.0. This reflects a software version update for the site rather than a change to study details.
    Difference
    0.1%
    Check dated 2026-06-26T23:55:38.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Recruitment status is updated to indicate no active enrollment. New help sections are added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment header is updated alongside a revision tag advancing to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T14:08:29.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    A new revision tag Revision: v3.5.5 has been added to the page. The previous revision tag Revision: v3.5.4 has been removed.
    Difference
    0.1%
    Check dated 2026-06-05T09:27:17.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4, signaling a new page version was published; such updates typically reflect editorial or backend adjustments rather than changes to essential content.
    Difference
    0.1%
    Check dated 2026-05-15T04:57:20.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.3, replacing Revision: v3.5.2, indicating a minor backend/content update without altering the study details.
    Difference
    0.1%
    Check dated 2026-04-30T18:23:56.000Z thumbnail image

Stay in the know with updates to Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial page.